Abstract:Pathologies of the vasculature including the microvasculature are often complex in nature, leading to loss of physiological homeostatic regulation of patency and adequate perfusion to match tissue metabolic demands. Microvascular dysfunction is a key underlying element in the majority of pathologies of failing organs and tissues. Contributing pathological factors to this dysfunction include oxidative stress, mitochondrial dysfunction, endoplasmic reticular (ER) stress, endothelial dysfunction, loss of angiogenic potential and vascular density, and greater senescence and apoptosis. In many clinical settings, current pharmacologic strategies use a single or narrow targeted approach to address symptoms of pathology rather than a comprehensive and multifaceted approach to address their root cause. To address this, efforts have been heavily focused on cellular therapies and cell-free therapies (e.g., exosomes) that can tackle the multifaceted etiology of vascular and microvascular dysfunction. In this review, we discuss 1) the state of the field in terms of common therapeutic cell population isolation techniques, their unique characteristics, and their advantages and disadvantages, 2) common molecular mechanisms of cell therapies to restore vascularization and/or vascular function, 3) arguments for and against allogeneic versus autologous applications of cell therapies, 4) emerging strategies to optimize and enhance cell therapies through priming and preconditioning, and, finally, 5) emerging strategies to bolster therapeutic effect. Relevant and recent clinical and animal studies using cellular therapies to restore vascular function or pathologic tissue health by way of improved vascularization are highlighted throughout these sections.

Therapeutic Angiogenesis and Tissue Revascularization in Ischemic Vascular Disease

Therapeutic neovascularization for ischemic heart disease

Therapeutic Angiogenesis for Brain Ischemia: A Brief Review

Therapeutic neovascularization for coronary disease: current state and future prospects

Vascular Growth in Ischemic Limbs: A Review of Mechanisms and Possible Therapeutic Stimulation

Cell-modified Bioprinted Microspheres for Vascular Regeneration

Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease

[Advances in Research of the Strategies for Promoting Angiogenesis in Tissue Engineering].

Therapeutic Angiogenesis and Cardiovascular Disease: A Review

Endothelial Progenitor Cells and In-stent Restenosis.

EphrinB2/EphB4 Pathway in Postnatal Angiogenesis: a Potential Therapeutic Target for Ischemic Cardiovascular Disease

[Advances in the Research of Mechanisms of Promotion of Vascularization by Angiogenin and Its Application].

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Advances in neovascularization after diabetic ischemia

Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases

State of the field: cellular and exosomal therapeutic approaches in vascular regeneration

Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia

Rebuilding the Vascular Network: In vivo and in vitro Approaches

Application of stem cells in engineered vascular graft and vascularized organs

Pioneering therapies for post-infarction angiogenesis: Insight into molecular mechanisms and preclinical studies

Emerging Biomaterials-Based Strategies for Inhibiting Vasculature Function in Cancer Therapy